Results 181 to 190 of about 694,898 (303)

Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation. [PDF]

open access: yesIntern Med
Watanabe M   +9 more
europepmc   +1 more source

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

open access: yesNew England Journal of Medicine, 1995
R. Zittoun   +20 more
semanticscholar   +1 more source

Nationwide study of COVID-19 outcomes in hematologic patients following bone marrow transplantation. [PDF]

open access: yesSci Rep
Garcia-Carretero R   +5 more
europepmc   +1 more source

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany

open access: yesInternational Journal of Cancer, EarlyView.
Molecular tumor boards (MTB), interdisciplinary teams that use tumor genomic data to guide personalized treatment decisions, have emerged as a promising strategy in melanoma care, although their real‐world clinical impact remains uncertain. This retrospective study evaluated advanced melanoma patients to assess molecularly guided treatment ...
Glenn Geidel   +26 more
wiley   +1 more source

Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation. [PDF]

open access: yesBMC Cancer
Pituskin E   +24 more
europepmc   +1 more source

Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees.

open access: yesOsteoarthritis and Cartilage, 2002
S. Wakitani   +5 more
semanticscholar   +1 more source

Comparison of Relapse Risk Prediction Models During Active Surveillance in Stage I Seminoma: A Retrospective Multicenter Cohort Study

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT To improve the prediction of relapse for clinical stage I seminoma, we aimed to validate the Boormans model (incorporating tumor size, rete testis invasion, and lymphovascular invasion) against the conventional classification (tumor size > 4 cm/rete testis invasion).
Andreas Banner   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy